Results 241 to 250 of about 271,655 (296)
HIV infection and survival in Hodgkin lymphoma: a real-world analysis of a multicenter research network. [PDF]
JNCI Cancer SpectrLin SP, Yen TH, Li JR, Chou CW.
europepmc +1 more source
Prognostic Value of Spatial and Topological Features of Tumor Microenvironment in Classic Hodgkin Lymphoma. [PDF]
Oncol ResBernal-Florindo I +9 more
europepmc +1 more source
Pediatric Mediastinal Gray Zone Lymphoma With Germline TET2 Heterozygous Variant
Pediatric Blood &Cancer, Volume 73, Issue 11, November 2026.
Matthew R. Schuelke +9 more
wiley +1 more source
Aging cells, young patients: senescence in Hodgkin lymphoma. [PDF]
Blood AdvKong IY, Giulino-Roth L, Steidl C.
europepmc +1 more source
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial. [PDF]
Nat MedHutchings M +24 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet, 2003
Hodgkin's lymphoma was first described in 1832, but the nature of the pathognomic Reed-Sternberg cell, on which diagnosis of the disease is based, has only been elucidated in the past few years. Radiotherapy has been used to treat localised disease since the 1940s, and in the 1960s, effective combination chemotherapy regimens were introduced for ...
Lynny, Yung, David, Linch
openaire +2 more sources
Hodgkin's lymphoma was first described in 1832, but the nature of the pathognomic Reed-Sternberg cell, on which diagnosis of the disease is based, has only been elucidated in the past few years. Radiotherapy has been used to treat localised disease since the 1940s, and in the 1960s, effective combination chemotherapy regimens were introduced for ...
Lynny, Yung, David, Linch
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 2013
Hodgkin lymphoma (HL) is a curable malignancy which shows a bimodal curve in incidence in economically developed countries; there is a putative association with Epstein-Barr virus. The WHO 2008 classification schema recognises two histological types of HL: the nodular lymphocyte predominant and the "classic" HL.
GOBBI, PAOLO +3 more
openaire +3 more sources
Hodgkin lymphoma (HL) is a curable malignancy which shows a bimodal curve in incidence in economically developed countries; there is a putative association with Epstein-Barr virus. The WHO 2008 classification schema recognises two histological types of HL: the nodular lymphocyte predominant and the "classic" HL.
GOBBI, PAOLO +3 more
openaire +3 more sources
Current Problems in Cancer, 2006
An estimated 8,490 new cases of Hodgkin’s lymphoma were diagnosed in the USA in 2010. Reed–Sternberg cells are the malignant cells in classical Hodgkin’s lymphoma (CD15+, CD30+, and CD45−). In nodular lymphocyte-predominant Hodgkin’s lymphoma (NLPHL), these cells express B-cell markers (CD20+, CD79a+, and CD45+) and are CD15− and CD30 ...
Richard W, Tsang +2 more
openaire +2 more sources
An estimated 8,490 new cases of Hodgkin’s lymphoma were diagnosed in the USA in 2010. Reed–Sternberg cells are the malignant cells in classical Hodgkin’s lymphoma (CD15+, CD30+, and CD45−). In nodular lymphocyte-predominant Hodgkin’s lymphoma (NLPHL), these cells express B-cell markers (CD20+, CD79a+, and CD45+) and are CD15− and CD30 ...
Richard W, Tsang +2 more
openaire +2 more sources
Nursing Standard, 2004
Hodgkin's lymphoma is a malignant disease of the lymphatic system. This article gives an overview of the disease process and the classification and staging of Hodgkin's lymphoma. The nursing care and psychological support of these patients during radiotherapy and chemotherapy treatment are also discussed.
Sylvia, Cole, Kathleen, Dunne
openaire +2 more sources
Hodgkin's lymphoma is a malignant disease of the lymphatic system. This article gives an overview of the disease process and the classification and staging of Hodgkin's lymphoma. The nursing care and psychological support of these patients during radiotherapy and chemotherapy treatment are also discussed.
Sylvia, Cole, Kathleen, Dunne
openaire +2 more sources
The Lancet, 2017
Lymphomas can affect any organ in the body, present with a wide range of symptoms, and be seen by primary care physicians and physicians from most specialties. They are traditionally divided into Hodgkin's lymphoma (which accounts for about 10% of all lymphomas) and non-Hodgkin lymphoma, which is the topic of this Seminar.
Zeppa P., Cozzolino I.
openaire +4 more sources
Lymphomas can affect any organ in the body, present with a wide range of symptoms, and be seen by primary care physicians and physicians from most specialties. They are traditionally divided into Hodgkin's lymphoma (which accounts for about 10% of all lymphomas) and non-Hodgkin lymphoma, which is the topic of this Seminar.
Zeppa P., Cozzolino I.
openaire +4 more sources